10-Q: Maquia Capital Acquisition Corp. Reports Q1 2024 Results Amidst Business Combination Termination and Delisting Concerns
Quarterly Report
Maquia Capital Acquisition Corporation reports a net loss for Q1 2024, faces business combination termination, and is under threat of delisting from Nasdaq.
Summary
- Maquia Capital Acquisition Corporation reported a net loss of $162,958 for the quarter ended March 31, 2024, compared to a net income of $278,260 for the same period in 2023.
- The company's operating expenses were $237,978, and it experienced a loss on the change in fair value of derivative liabilities of $45,744.
- The company had unrealized gains on investments of $154,497.
- The company's cash and cash equivalents stood at $196,833 as of March 31, 2024.
- The company has a working capital deficiency of $4,145,758.
- A business combination agreement with Immersed, Inc. was terminated on May 20, 2024.
- The company is facing potential delisting from Nasdaq due to non-compliance with listing rules, including failure to file its 10Q report on time and not completing a business combination within 36 months of its IPO.
- The company has until August 7, 2024, to complete a business combination, or it will be forced to liquidate.
- The company has overdrawn its trust account by $293,209 for taxes, and the sponsor has not yet replenished the trust for the additional $44,909 overdrawn in the three months ended March 31, 2024.
- The company's sponsor has replenished $208,342 to the trust account due to overpayment to redeeming stockholders in 2023.
Sentiment
Score: 2
Explanation: The document presents a very negative outlook due to the net loss, terminated business combination, potential delisting, and going concern issues. The company is facing significant challenges and has a limited time to resolve them.
Positives
- The company had unrealized gains on investments of $154,497 in Q1 2024.
- The sponsor has replenished $208,342 to the trust account due to overpayment to redeeming stockholders in 2023.
Negatives
- The company reported a net loss of $162,958 for Q1 2024.
- The company's operating expenses were $237,978.
- The company experienced a loss on the change in fair value of derivative liabilities of $45,744.
- The company has a working capital deficiency of $4,145,758.
- The business combination agreement with Immersed, Inc. was terminated.
- The company is facing potential delisting from Nasdaq.
- The company has overdrawn its trust account by $293,209 for taxes.
Risks
- The company's ability to complete a business combination by August 7, 2024, is uncertain.
- The company faces the risk of delisting from Nasdaq due to non-compliance with listing rules.
- The company's financial statements do not include adjustments that may be necessary should the company be unable to continue as a going concern.
- The company has a working capital deficiency of $4,145,758.
- The company has overdrawn its trust account by $293,209 for taxes.
- The termination of the business combination agreement with Immersed, Inc. severely limits the company's ability to consummate a business combination with a new target prior to August 7, 2024.
Future Outlook
The company intends to continue to identify and pursue a business combination with an appropriate target, but faces significant challenges due to the upcoming deadline and potential delisting from Nasdaq.
Management Comments
- The company's management is currently evaluating the impact of the COVID-19 pandemic.
- Management believes the company is not exposed to significant risks on its cash account.
- Management is seeking to maximize the use of observable inputs and minimize the use of unobservable inputs in fair value measurements.
Industry Context
The document highlights the challenges faced by SPACs in the current market, including difficulties in finding suitable targets and maintaining compliance with listing requirements. The termination of the business combination agreement and the potential delisting are indicative of the broader challenges in the SPAC market.
Comparison to Industry Standards
- The company's financial performance is below industry standards for SPACs, as it has not yet completed a business combination and is incurring losses.
- The company's cash position is weak compared to other SPACs, and it has a significant working capital deficiency.
- The company's challenges with Nasdaq listing compliance are not unique, as many SPACs face similar issues due to the time constraints and regulatory requirements.
- The termination of the business combination agreement is a negative development, as it further delays the company's ability to complete a transaction and return value to shareholders.
- The company's overdrawn trust account and the need for sponsor loans are also indicative of the financial pressures faced by many SPACs.
Related Party Transactions
- The company has related party loans with the sponsor.
- The sponsor has made contributions to the trust account in connection with extensions.
- The sponsor has agreed to transfer shares to third parties in exchange for non-redemption agreements.
Stakeholder Impact
- Shareholders face the risk of losing their investment if the company is unable to complete a business combination and is liquidated.
- The potential delisting from Nasdaq could negatively impact the value of the company's securities.
- The company's employees and management face uncertainty about the company's future.
- Creditors face the risk of not being repaid if the company is liquidated.
Next Steps
- The company intends to continue to identify and pursue a business combination with an appropriate target.
- The company must address the Nasdaq delisting notice and regain compliance with listing rules.
- The company must complete a business combination by August 7, 2024, or face liquidation.
Key Dates
| Date | Description |
|---|---|
| 2020-12-10 | Maquia Capital Acquisition Corporation incorporated in Delaware. |
| 2021-01-28 | Initial founder shares issued. |
| 2021-05-04 | Registration statement for IPO declared effective. |
| 2021-05-07 | Initial Public Offering (IPO) closed. |
| 2021-05-10 | Over-allotment option partially exercised. |
| 2022-11-04 | Special meeting to extend business combination deadline to May 7, 2023. |
| 2023-05-05 | Special meeting to extend business combination deadline to February 7, 2024. |
| 2023-08-08 | Business Combination Agreement executed with Immersed, Inc. |
| 2024-02-05 | Special meeting to extend business combination deadline to August 7, 2024. |
| 2024-04-05 | Amendment No. 3 to the Business Combination Agreement extending the closing date to May 7, 2024. |
| 2024-05-07 | Maquia received a notice from Nasdaq that it was not in compliance with Nasdaq Listing Rule IM-5101-2. |
| 2024-05-20 | Business Combination Agreement with Immersed, Inc. terminated. |
| 2024-05-22 | Maquia received a notice from Nasdaq that it was delinquent in the filing of its periodic Form 10Q Report. |
| 2024-06-20 | Hearing date for Nasdaq delisting appeal. |
Keywords
SPAC, Business Combination, Delisting, Nasdaq, Financial Results, Net Loss, Working Capital, Trust Account, Redemption, Warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.